<p>The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.</p>
KARSTENS, WILLEM FREDERIK JOHAN;STELT, MARIO VAN DER;CALS, JOS;AZEVEDO, RITA CORTE REAL GONCALVES;BARR, KENNETH JAY;ZHANG, HONGJUN;BERESIS, RICHARD THOMAS;ZHANG, DONGSHAN;DUAN, XIAOBANG
